Cannell & Spears’s CME Group CME Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $603K | Sell |
2,187
-372
| -15% | -$103K | 0.01% | 268 |
|
2025
Q1 | $679K | Sell |
2,559
-1,275
| -33% | -$338K | 0.01% | 258 |
|
2024
Q4 | $890K | Sell |
3,834
-546
| -12% | -$127K | 0.02% | 246 |
|
2024
Q3 | $967K | Sell |
4,380
-9,764
| -69% | -$2.15M | 0.02% | 240 |
|
2024
Q2 | $2.78M | Sell |
14,144
-12,332
| -47% | -$2.42M | 0.06% | 155 |
|
2024
Q1 | $5.7M | Buy |
26,476
+1,009
| +4% | +$217K | 0.12% | 121 |
|
2023
Q4 | $5.36M | Sell |
25,467
-1,846
| -7% | -$389K | 0.43% | 35 |
|
2023
Q3 | $5.47M | Sell |
27,313
-5,700
| -17% | -$1.14M | 0.47% | 35 |
|
2023
Q2 | $6.12M | Sell |
33,013
-859
| -3% | -$159K | 0.5% | 32 |
|
2023
Q1 | $6.49M | Buy |
33,872
+4,595
| +16% | +$880K | 0.58% | 31 |
|
2022
Q4 | $4.92M | Buy |
29,277
+5,794
| +25% | +$974K | 0.47% | 39 |
|
2022
Q3 | $4.16M | Sell |
23,483
-258
| -1% | -$45.7K | 0.41% | 43 |
|
2022
Q2 | $4.86M | Sell |
23,741
-668
| -3% | -$137K | 0.44% | 41 |
|
2022
Q1 | $5.81M | Sell |
24,409
-4,934
| -17% | -$1.17M | 0.43% | 37 |
|
2021
Q4 | $6.7M | Sell |
29,343
-5,617
| -16% | -$1.28M | 0.45% | 36 |
|
2021
Q3 | $6.76M | Sell |
34,960
-75
| -0.2% | -$14.5K | 0.49% | 36 |
|
2021
Q2 | $7.45M | Buy |
35,035
+382
| +1% | +$81.2K | 0.54% | 32 |
|
2021
Q1 | $7.08M | Sell |
34,653
-415
| -1% | -$84.8K | 0.55% | 32 |
|
2020
Q4 | $6.38M | Buy |
35,068
+439
| +1% | +$79.9K | 0.53% | 31 |
|
2020
Q3 | $5.79M | Buy |
34,629
+6,520
| +23% | +$1.09M | 0.55% | 32 |
|
2020
Q2 | $4.57M | Sell |
28,109
-381
| -1% | -$61.9K | 0.48% | 39 |
|
2020
Q1 | $4.93M | Buy |
+28,490
| New | +$4.93M | 0.6% | 34 |
|